Good citation @Jonotr0n. Still some work for the team to do here which is why I think today's price is going to be somewhat subdued. I have full confidence that they will be able to improve upon these results overtime, but that's what many traders lack unfortunately.
What is very encouraging is that they have found something else that is showing potential in combating staph. The challenge now is to turn that potential into a commercially viable product and we're still a long way off from that happening. Nonetheless, some further successful studies and BOT could be shaping up as a takeover target, but not quite yet (this year) in my view.
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-179
-
- There are more pages in this discussion • 822 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.3¢ | 34.5¢ | $582.2K | 1.679M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32454 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 210000 | 3 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |